Citigroup Inc. Sells 199,450 Shares of Cardinal Health, Inc. (NYSE:CAH)

Citigroup Inc. lowered its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 33.8% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 390,978 shares of the company’s stock after selling 199,450 shares during the period. Citigroup Inc. owned approximately 0.16% of Cardinal Health worth $53,865,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Greykasell Wealth Strategies Inc. bought a new position in shares of Cardinal Health during the 1st quarter valued at about $26,000. Tompkins Financial Corp lifted its holdings in shares of Cardinal Health by 106.7% during the 1st quarter. Tompkins Financial Corp now owns 248 shares of the company’s stock valued at $34,000 after purchasing an additional 128 shares in the last quarter. Bellwether Advisors LLC bought a new position in shares of Cardinal Health during the 4th quarter valued at about $32,000. GW&K Investment Management LLC lifted its holdings in shares of Cardinal Health by 113.4% during the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock valued at $37,000 after purchasing an additional 144 shares in the last quarter. Finally, Itau Unibanco Holding S.A. bought a new position in shares of Cardinal Health during the 4th quarter valued at about $36,000. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Up 2.6%

NYSE:CAH opened at $157.44 on Monday. The firm has a market capitalization of $37.58 billion, a price-to-earnings ratio of 24.56, a price-to-earnings-growth ratio of 1.56 and a beta of 0.67. Cardinal Health, Inc. has a twelve month low of $98.07 and a twelve month high of $168.44. The stock’s 50 day moving average price is $160.05 and its two-hundred day moving average price is $143.96.

Analysts Set New Price Targets

Several research firms have recently weighed in on CAH. UBS Group lifted their price objective on Cardinal Health from $150.00 to $160.00 and gave the company a “buy” rating in a report on Tuesday, April 29th. Wall Street Zen lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 2nd. Robert W. Baird lifted their target price on Cardinal Health from $156.00 to $170.00 and gave the company an “outperform” rating in a research report on Friday, May 2nd. Citigroup reissued a “neutral” rating and issued a $170.00 target price (up previously from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Finally, Evercore ISI reissued an “outperform” rating and issued a $180.00 target price (up previously from $175.00) on shares of Cardinal Health in a research report on Thursday, June 12th. Three equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $158.07.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.